BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 7776989)

  • 1. Apoptosis and loss of renal tissue in polycystic kidney diseases.
    Woo D
    N Engl J Med; 1995 Jul; 333(1):18-25. PubMed ID: 7776989
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered Hippo signalling in polycystic kidney disease.
    Happé H; van der Wal AM; Leonhard WN; Kunnen SJ; Breuning MH; de Heer E; Peters DJ
    J Pathol; 2011 May; 224(1):133-42. PubMed ID: 21381034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of a modified low protein and low fat diet on histologic changes and metabolism in kidneys in an experimental model of polycystic kidney disease].
    Banković-Calić N; Ogbori MR; Nicman E
    Srp Arh Celok Lek; 2002; 130(7-8):251-7. PubMed ID: 12585002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distribution and ontogenesis of tenascin in normal and cystic human fetal kidneys.
    Daïkha-Dahmane F; Dommergues M; Narcy F; Lacoste M; Gubler MC
    Lab Invest; 1995 Oct; 73(4):547-57. PubMed ID: 7474927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammalian target of rapamycin and autosomal dominant polycystic kidney disease.
    Wüthrich RP; Serra AL
    Transplant Proc; 2009; 41(6 Suppl):S18-20. PubMed ID: 19651290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic kidney disease: huge kidneys, huge problems, huge progress.
    Grantham JJ
    Trans Am Clin Climatol Assoc; 1997; 108():165-70; discussion 170-2. PubMed ID: 9108675
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequent apoptosis in human kidneys after acute renal hypoperfusion.
    Jaffe R; Ariel I; Beeri R; Paltiel O; Hiss Y; Rosen S; Brezis M
    Exp Nephrol; 1997; 5(5):399-403. PubMed ID: 9386976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of progression in autosomal dominant polycystic kidney disease.
    Grantham JJ
    Kidney Int Suppl; 1997 Dec; 63():S93-7. PubMed ID: 9407432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new murine model of autosomal recessive polycystic kidney disease.
    Ozawa Y; Nauta J; Sweeney WE; Avner ED
    Nihon Jinzo Gakkai Shi; 1993 Apr; 35(4):349-54. PubMed ID: 8341011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Renal failure and cystic kidney diseases].
    Correas JM; Joly D; Chauveau D; Richard S; Hélénon O
    J Radiol; 2011 Apr; 92(4):308-22. PubMed ID: 21549887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced Pax2 gene dosage increases apoptosis and slows the progression of renal cystic disease.
    Ostrom L; Tang MJ; Gruss P; Dressler GR
    Dev Biol; 2000 Mar; 219(2):250-8. PubMed ID: 10694420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
    Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
    Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA fragmentation in acute and chronic rejection after renal transplantation.
    Ott U; Aschoff A; Fünfstück R; Jirikowski G; Wolf G
    Transplant Proc; 2007; 39(1):73-7. PubMed ID: 17275477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autosomal dominant polycystic kidney disease: MR imaging evaluation using current techniques.
    Mosetti MA; Leonardou P; Motohara T; Kanematsu M; Armao D; Semelka RC
    J Magn Reson Imaging; 2003 Aug; 18(2):210-5. PubMed ID: 12884334
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine autosomal recessive polycystic kidney disease with multiorgan involvement induced by the cpk gene.
    Gattone VH; MacNaughton KA; Kraybill AL
    Anat Rec; 1996 Jul; 245(3):488-99. PubMed ID: 8800407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease.
    Ye M; Grantham JJ
    N Engl J Med; 1993 Jul; 329(5):310-3. PubMed ID: 8321258
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
    Schrier RW
    J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood pressure, functional and morphological study of kidneys in children with autosomal dominant polycystic kidney disease].
    Seeman T; Vondrichová H; Strízová J; Sikut M; Janda J; Schärer K
    Cas Lek Cesk; 1999 Mar; 138(6):178-84. PubMed ID: 10510532
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pck rat: a new model that resembles human autosomal dominant polycystic kidney and liver disease.
    Lager DJ; Qian Q; Bengal RJ; Ishibashi M; Torres VE
    Kidney Int; 2001 Jan; 59(1):126-36. PubMed ID: 11135065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasticity of epithelial cells derived from human normal and ADPKD kidneys in primary cultures.
    Elberg G; Guruswamy S; Logan CJ; Chen L; Turman MA
    Cell Tissue Res; 2008 Feb; 331(2):495-508. PubMed ID: 18004594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.